207 related articles for article (PubMed ID: 11081635)
1. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.
Motyka B; Korbutt G; Pinkoski MJ; Heibein JA; Caputo A; Hobman M; Barry M; Shostak I; Sawchuk T; Holmes CF; Gauldie J; Bleackley RC
Cell; 2000 Oct; 103(3):491-500. PubMed ID: 11081635
[TBL] [Abstract][Full Text] [Related]
2. A clathrin/dynamin- and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death.
Trapani JA; Sutton VR; Thia KY; Li YQ; Froelich CJ; Jans DA; Sandrin MS; Browne KA
J Cell Biol; 2003 Jan; 160(2):223-33. PubMed ID: 12538642
[TBL] [Abstract][Full Text] [Related]
3. Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate.
Veugelers K; Motyka B; Goping IS; Shostak I; Sawchuk T; Bleackley RC
Mol Biol Cell; 2006 Feb; 17(2):623-33. PubMed ID: 16280358
[TBL] [Abstract][Full Text] [Related]
4. Dietary omega-3 polyunsaturated fatty acids can inhibit expression of granzyme B, perforin, and cation-independent mannose 6-phosphate/insulin-like growth factor receptor in rat model of small bowel transplant chronic rejection.
Kun Z; Haiyun Z; Meng W; Li Ning ; Li Yousheng ; Li Jieshou
JPEN J Parenter Enteral Nutr; 2008; 32(1):12-7. PubMed ID: 18165442
[TBL] [Abstract][Full Text] [Related]
5. Unimpaired allorejection of cells deficient for the mannose 6-phosphate receptors Mpr300 and Mpr46.
Dressel R; von Figura K; Günther E
Transplantation; 2004 Sep; 78(5):758-61. PubMed ID: 15371683
[TBL] [Abstract][Full Text] [Related]
6. Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor.
Griffiths GM; Isaaz S
J Cell Biol; 1993 Feb; 120(4):885-96. PubMed ID: 8432729
[TBL] [Abstract][Full Text] [Related]
7. Localization of granzyme B in the nucleus. A putative role in the mechanism of cytotoxic lymphocyte-mediated apoptosis.
Trapani JA; Browne KA; Smyth MJ; Jans DA
J Biol Chem; 1996 Feb; 271(8):4127-33. PubMed ID: 8626751
[TBL] [Abstract][Full Text] [Related]
8. The granzyme B-serglycin complex from cytotoxic granules requires dynamin for endocytosis.
Veugelers K; Motyka B; Frantz C; Shostak I; Sawchuk T; Bleackley RC
Blood; 2004 May; 103(10):3845-53. PubMed ID: 14739229
[TBL] [Abstract][Full Text] [Related]
9. Granzyme-mediated cytotoxicity does not involve the mannose 6-phosphate receptors on target cells.
Dressel R; Raja SM; Höning S; Seidler T; Froelich CJ; von Figura K; Günther E
J Biol Chem; 2004 May; 279(19):20200-10. PubMed ID: 14985351
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; Piñeiro A; Naval J
J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942
[TBL] [Abstract][Full Text] [Related]
11. Nephritogenic T cells use granzyme C as a cytotoxic mediator.
Bailey NC; Kelly CJ
Eur J Immunol; 1997 Sep; 27(9):2302-9. PubMed ID: 9341773
[TBL] [Abstract][Full Text] [Related]
12. Granzyme B-mediated death of pancreatic beta-cells requires the proapoptotic BH3-only molecule bid.
Estella E; McKenzie MD; Catterall T; Sutton VR; Bird PI; Trapani JA; Kay TW; Thomas HE
Diabetes; 2006 Aug; 55(8):2212-9. PubMed ID: 16873683
[TBL] [Abstract][Full Text] [Related]
13. Trichosanthin increases Granzyme B penetration into tumor cells by upregulation of CI-MPR on the cell surface.
Li C; Zeng M; Chi H; Shen J; Ng TB; Jin G; Lu D; Fan X; Xiong B; Xiao Z; Sha O
Oncotarget; 2017 Apr; 8(16):26460-26470. PubMed ID: 28460437
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: granzymes A and B are not essential for perforin-mediated tumor rejection.
Smyth MJ; Street SE; Trapani JA
J Immunol; 2003 Jul; 171(2):515-8. PubMed ID: 12847210
[TBL] [Abstract][Full Text] [Related]
15. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes.
Sun J; Bird CH; Sutton V; McDonald L; Coughlin PB; De Jong TA; Trapani JA; Bird PI
J Biol Chem; 1996 Nov; 271(44):27802-9. PubMed ID: 8910377
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis.
Willoughby CA; Bull HG; Garcia-Calvo M; Jiang J; Chapman KT; Thornberry NA
Bioorg Med Chem Lett; 2002 Aug; 12(16):2197-200. PubMed ID: 12127536
[TBL] [Abstract][Full Text] [Related]
17. Granzyme B: a natural born killer.
Lord SJ; Rajotte RV; Korbutt GS; Bleackley RC
Immunol Rev; 2003 Jun; 193():31-8. PubMed ID: 12752668
[TBL] [Abstract][Full Text] [Related]
18. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
19. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins.
Odake S; Kam CM; Narasimhan L; Poe M; Blake JT; Krahenbuhl O; Tschopp J; Powers JC
Biochemistry; 1991 Feb; 30(8):2217-27. PubMed ID: 1998680
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria at the heart of the cytotoxic attack.
Roberts DL; Goping IS; Bleackley RC
Biochem Biophys Res Commun; 2003 May; 304(3):513-8. PubMed ID: 12729586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
